EEG Machine Learning for Antidepressant Response Stratification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing antidepressant treatments for depression show only a small overall advantage over placebo, and there is a need for objective measures to stratify depressed patients into those who benefit significantly from antidepressants and those who do not, due to the heterogeneous nature of depression phenotypes.

Innovation Solution

A Sparse Electroencephalography Latent SpacE Regression (SELSER) computational model is used to analyze brain signals from patients to predict treatment outcomes, identifying antidepressant-responsive depression phenotypes by training a machine learning model to minimize prediction error through optimizing latent signals.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antidepressant medications are used to treat depression, then treatment coverage is provided for a broad population, but treatment efficacy is only marginally superior to placebo due to heterogeneity in depression phenotypes

Engineering Contradiction:
Improvetreatment efficacyVSAvoidphenotype heterogeneity
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent segments the heterogeneous depression population into distinct phenotypic subgroups using machine learning analysis of EEG data. By dividing the broad depression category into smaller, more homogeneous groups based on neural activity patterns, the treatment can be tailored to each subgroup, thereby improving overall treatment efficacy while accounting for phenotype heterogeneity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies local quality by identifying specific neural activity patterns (local characteristics) that distinguish different depression phenotypes. Rather than treating all depression uniformly, the approach focuses on local variations in brain function captured by EEG signals to personalize treatment recommendations for each phenotypic subgroup.

Inventive Principle:
Principle #3Local quality

2Measurement precision

If machine learning models analyze complex brain signals to predict treatment response, then prediction accuracy is improved, but model complexity and computational requirements increase

Engineering Contradiction:
Improvetreatment outcome prediction accuracyVSAvoidmodel complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent extracts the most relevant features from complex EEG brain signals to feed into the machine learning model. By selecting and extracting only the most predictive neural activity patterns rather than processing all raw signal data, the model achieves high prediction accuracy while reducing computational complexity and making the system more practical for clinical deployment.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS12490933B2Treatment of depression using machine learning
Publication Date: 2025.12.09 BOARD OF RGT THE UNIV OF TEXAS SYST
  • US12490933B2 patent drawing
  • US12490933B2 patent drawing
  • US12490933B2 patent drawing

AI summary

Provided herein are, inter alia, methods for identifying subjects suffering from depression that will respond to treatment with an antidepressant.